INTERMEDIATE RISK PROSTATE CANCER
Clinical trials for INTERMEDIATE RISK PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new INTERMEDIATE RISK PROSTATE CANCER trials appear
Sign up with your email to follow new studies for INTERMEDIATE RISK PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New electric pulse therapy could replace radiation boost for prostate cancer
Disease control Recruiting nowThis study compares a new boost approach called irreversible electroporation (IRE) using the NanoKnife system against the standard radiation boost for men with intermediate-risk prostate cancer. All participants will receive standard stereotactic body radiation therapy (SBRT), bu…
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Phase: PHASE3 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo therapy aims to treat prostate cancer with fewer side effects
Disease control Recruiting nowThis phase 2 trial is testing whether combining focal prostate ablation (a surgery that destroys only the cancerous part of the prostate) with a short course of hormone therapy can effectively treat intermediate-risk prostate cancer. The study will enroll 57 participants and meas…
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Zapping prostate tumors without major side effects: new trial launches
Disease control Recruiting nowThis study tests a procedure called irreversible electroporation (IRE) using the NanoKnife system to treat intermediate-risk prostate cancer. The goal is to destroy cancer cells with fewer side effects than standard treatments like surgery or radiation. About 100 men over age 50 …
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Precision freezing targets prostate cancer, spares healthy tissue
Disease control Recruiting nowThis study tests whether freezing only the part of the prostate that contains cancer (focal cryotherapy) can control intermediate-risk prostate cancer. About 30 men with a single area of cancer will receive this targeted treatment. The goal is to reduce side effects while keeping…
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could 2 sessions of proton therapy be enough for prostate cancer?
Disease control Recruiting nowThis study is testing a new, shorter way to treat prostate cancer using proton therapy. Instead of the usual 5 sessions, researchers want to see if just 2 sessions are as safe and effective. The goal is to make treatment faster and more affordable while keeping side effects low. …
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Phase: NA • Sponsor: Hong Kong Sanatorium & Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Precision radiation targets prostate tumors with MRI guidance
Disease control Recruiting nowThis study tests a new way to deliver radiation for intermediate-risk prostate cancer. Using an MRI machine that also delivers radiation, doctors can give a higher dose to the main tumor while lowering the dose to the rest of the prostate. The goal is to improve tumor control and…
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Phase: NA • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New radiation technique aims to protect erections in prostate cancer patients
Disease control Recruiting nowThis study tests a precise type of radiation therapy (MRgRT) that aims to protect the nerves and blood vessels needed for erections in 70 men with low- or intermediate-risk prostate cancer. Participants receive 5 high-dose radiation sessions guided by MRI. The goal is to see if t…
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Phase: NA • Sponsor: UMC Utrecht • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
GPS-Guided prostate radiation: could 3 doses be better than 5?
Disease control Recruiting nowThis study is testing whether giving only 3 doses of high-precision radiation (SBRT) over 3 days is as safe and effective as the usual 5-dose schedule for men with low or intermediate risk prostate cancer. The radiation is guided by a special catheter that acts like a GPS, tracki…
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Phase: NA • Sponsor: NHS Lothian • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Weight-Loss drug tested before prostate surgery in new pilot study
Symptom relief Recruiting nowThis early-phase study tests whether a weight-loss drug called tirzepatide can help overweight or obese men with intermediate-risk prostate cancer lose weight before their prostate removal surgery. The study will enroll 30 participants and focus on safety and how well the program…
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New imaging technique aims to sharpen prostate cancer radiation
Knowledge-focused Recruiting nowThis study is for men with intermediate- or high-risk prostate cancer who will receive hormone therapy and radiation. Researchers want to see if using a special PET scan (PSMA PET) during hormone therapy can help doctors better target remaining cancer with radiation while avoidin…
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Phase: PHASE2 • Sponsor: Martin T. King, MD, PhD • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC